Maximising clinical benefit with adequate patient management beyond the second line in mCRC

Argiles, G; Arnold, D; Prager, G; Sobrero, AF; Van Cutsem, E

Argiles, G (reprint author), Hosp Valle De Hebron, Med Oncol, Barcelona, Spain.

ESMO OPEN, 2019; 4 (2):

Abstract

New therapeutic options for refractory metastatic colorectal cancer (mCRC) include trifluridine/tipiracil (TAS-102) and regorafenib. However, the opti......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索